2026 Michael A. Rogawski: Neuroscience Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	102	714	640	400	349	433	34067
Medicine	102	7735	7269	4027	3723	433	34051

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

102

714

640

400

349

433

34067

Medicine

102

7735

7269

4027

3723

433

34051

Neuroscience

D-Index

102

Citations

34067

World Ranking

714

National Ranking

400

Medicine

D-Index

102

Citations

34051

World Ranking

7735

National Ranking

4027

Research.com Recognitions

2020 - Fellow, National Academy of Inventors
2018 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Michael A. Rogawski is affiliated with the University of California, Davis in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with a notable focus on subfields such as Psychiatry and Mental Health, Cellular and Molecular Neuroscience, Molecular Biology, Pediatrics, Perinatology and Child Health, and Pharmaceutical Science.

The main topics covered in their work include:

Epilepsy research and treatment
Neuroscience and Neuropharmacology Research
Ion channel regulation and function
Pharmacological Effects and Toxicity Studies
Advanced Drug Delivery Systems
Pesticide Exposure and Toxicity
Pharmaceutical studies and practices

Michael A. Rogawski has published extensively, with a concentration of their work appearing in journals such as:

Neurology
Archives of Toxicology
Epilepsia
Epilepsia Open
Neuropharmacology

Significant recent papers by Rogawski comprise:

"Mechanisms of action of currently used antiseizure drugs," Neuropharmacology, 2020
"Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy," JAMA Neurology, 2023
"Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial," Alzheimer's & Dementia Translational Research & Clinical Interventions, 2020
"Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats," Annals of the New York Academy of Sciences, 2020
"The chemical convulsant diisopropylfluorophosphate (DFP) causes persistent neuropathology in adult male rats independent of seizure activity," Archives of Toxicology, 2020

Frequent collaborators in Rogawski's research include:

Jacqueline A. French
Roger J. Porter
Emilio Perucca
Martin J. Brodie
Cynthia L. Harden

Throughout their career, Michael A. Rogawski has been recognized with awards such as:

Fellow, National Academy of Inventors, 2020
Fellow of the American Association for the Advancement of Science (AAAS), 2018

Best Publications

The neurobiology of antiepileptic drugs.

Michael A. Rogawski;Wolfgang Löscher

1490
Citations
d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor

Jean Pierre Mothet;Angèle T. Parent;Angèle T. Parent;Herman Wolosker;Roscoe O. Brady

1411
Citations
Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

Michael A. Rogawski;Roger J. Porter

971
Citations
Glia and epilepsy: excitability and inflammation

Orrin Devinsky;Annamaria Vezzani;Souhel Najjar;Nihal C. De Lanerolle

946
Citations
Neuroprotective and disease-modifying effects of the ketogenic diet

Maciej Gasior;Michael A. Rogawski;Adam L. Hartman;Adam L. Hartman

645
Citations
Molecular Targets for Antiepileptic Drug Development

Brian S. Meldrum;Michael A. Rogawski

604
Citations
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease

Michael A. Rogawski;Gary L. Wenk

572
Citations
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions

Michael A Rogawski;Wolfgang Löscher

565
Citations
Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

Jacqueline A. French;Gregory L. Krauss;Victor Biton;David Squillacote

556
Citations
Jasper's basic mechanisms of the epilepsies

Jeffrey L Noebels;Massimo Avoli;Michael A Rogawski;Richard W Olsen

548
Citations
Colchicine myopathy and neuropathy

Ralph W. Kuncl;Greg Duncan;Danny Watson;Kathy Alderson

479
Citations
GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan;Michael A. Rogawski

444
Citations
Mechanisms of action of currently used antiseizure drugs.

Graeme J. Sills;Michael A. Rogawski

440
Citations
Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.

T. G. Kokate;B. E. Svensson;Michael A Rogawski

437
Citations
Diverse mechanisms of antiepileptic drugs in the development pipeline

Michael A. Rogawski

432
Citations
The A-current: how ubiquitous a feature of excitable cells is it?

Michael A. Rogawski;Michael A. Rogawski

415
Citations
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

Michael A. Rogawski

411
Citations
Revisiting AMPA Receptors as an Antiepileptic Drug Target

Michael A. Rogawski

408
Citations
The Neuropharmacology of the Ketogenic Diet

Adam L. Hartman;Maciej Gasior;Eileen P.G. Vining;Michael A. Rogawski

399
Citations
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.

Doodipala S. Reddy;Michael A. Rogawski

336
Citations
Neuronal Synchronization and Thalamocortical Rhythms in Sleep, Wake and Epilepsy -- Jasper's Basic Mechanisms of the Epilepsies

Noebels Jl;Avoli M;Rogawski Ma;Olsen Rw

18
Citations